|
Johnson & Johnson has experienced a number of setbacks
in 2010 with the recall of a number of their products.
The U.S. Federal Drug Administration (FDA) recently released
findings from their inspection of Johnson & Johnson's drug manufacturing
plant in Las Piedras, Puerto Rico from between September and early November. They found
that the corporation failed to follow their own written quality control procedures,
that they overlooked manufacturing issues, and released market drug products
that should have been rejected due to quality violations.
The FDA issued a warning letter to the Las Piedras plant in
January, stating that they found significant violations of manufacturing rules
that led to faulty products that smelled like must and mold. At that time, Johnson
& Johnson traced the smell to chemicals used on wooden pallets for transporting
packaging materials. However, the recent inspection by the FDA shows that the
Las Piedras plant has yet to fully-address quality control issues.
Not an Isolated
Incident
While it seems as though Johnson & Johnson's quality
control issues could be tied to one plant in particular, it is not so. The FDA's
issues found at the Las Piedras plant correspond to those that also plagued Johnson
& Johnson's base in New Brunswick, New Jersey, which recalled Tylenol,
Motrin, and Benadryl, amongst other products this year.
According to The Wall Street Journal, Johnson &
Johnson also closed a plant in Fort Washington, Pennsylvania in efforts to
address manufacturing problems there as well. The oversight of quality control
is reportedly costing Johnson & Johnson millions of dollars in lost sales
and facility upgrades, in addition to potential liability lawsuits associated
with recalls from this location alone.
What other major quality control errors have you seen?
Source: The
Wall Street Journal
|
Good Answers:
"Almost" Good Answers: